Today: 6 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Mastercard stock price slips as UK fee-cap ruling adds to pressure on payments giants

Mastercard stock price slips as UK fee-cap ruling adds to pressure on payments giants

New York, Jan 16, 2026, 13:20 ET — Regular session Shares of Mastercard Incorporated slipped on Friday following a UK court decision that strengthened a regulator’s authority to cap certain cross-border card fees, adding to the growing list of policy risks facing payment networks. The stock dipped about 0.1% to $542.22 after earlier falling to $538.60. In London, a High Court judge dismissed Mastercard’s challenge, affirming that Britain’s Payments System Regulator can set price caps on interchange fees, though the exact limits and timeline remain undecided.
16 January 2026
·
ImmunityBio stock jumps 35% as ANKTIVA bladder cancer trial update puts FDA filing in view

ImmunityBio stock jumps 35% as ANKTIVA bladder cancer trial update puts FDA filing in view

New York, Jan 16, 2026, 12:51 PM EST — Regular session ImmunityBio shares jumped about 35% on Friday after the cancer drugmaker reported faster enrollment and stronger interim results in a key bladder cancer study for its ANKTIVA therapy. The stock was up $1.39 at $5.34 by 12:51 p.m. EST after hitting $5.53, with about 133 million shares traded. The company said more than 85% of patients are enrolled in its QUILT-2.005 trial and it is targeting a U.S. filing by the end of 2026; an interim analysis showed 85% of patients on ANKTIVA plus BCG stayed in complete response at six months versus 57% on BCG alone and 84% versus 52% at nine months.
16 January 2026
···
1 … 468 469 470 471 472 … 878

Stock Market Today

  • Patagonia Lithium (ASX:PL3) starts drilling Well 8 at Cilon after A$11.4m raise
    July 5, 2026, 9:05 PM EDT. Patagonia Lithium (ASX:PL3) started drilling Well 8 at its Cilon concession in Argentina after wrapping up an A$11.4 million capital raise. The target depth is 600m. The company got to 38m so far and put in steel casing, with the first porosity test coming at 70m. Patagonia also lodged its EIA response for a demo plant and got a positive ruling over Indigenous rights, moving permitting ahead. Well 8 will feed into an upgrade for the current Mineral Resource Estimate, which is 551,400 tonnes lithium carbonate equivalent at 294 mg/L. The planned demonstration plant is set for 1,000 tonnes annual capacity and is needed to unlock project finance. Next up: approvals from the community and government for construction.
Go toTop